nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylprednisolone—systemic lupus erythematosus—focal segmental glomerulosclerosis	0.886	1	CtDrD
Methylprednisolone—ABCB1—Cyclosporine—focal segmental glomerulosclerosis	0.0338	0.625	CbGbCtD
Methylprednisolone—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.0202	0.375	CbGbCtD
Methylprednisolone—Benign intracranial hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.00311	0.0516	CcSEcCtD
Methylprednisolone—Papilloedema—Cyclosporine—focal segmental glomerulosclerosis	0.00287	0.0477	CcSEcCtD
Methylprednisolone—Atrophy—Cyclosporine—focal segmental glomerulosclerosis	0.0028	0.0465	CcSEcCtD
Methylprednisolone—Hypertrichosis—Cyclosporine—focal segmental glomerulosclerosis	0.0024	0.0399	CcSEcCtD
Methylprednisolone—Trauma—Cyclosporine—focal segmental glomerulosclerosis	0.00192	0.0318	CcSEcCtD
Methylprednisolone—Hirsutism—Cyclosporine—focal segmental glomerulosclerosis	0.00157	0.0261	CcSEcCtD
Methylprednisolone—Fracture—Cyclosporine—focal segmental glomerulosclerosis	0.00157	0.0261	CcSEcCtD
Methylprednisolone—Multiple fractures—Cyclosporine—focal segmental glomerulosclerosis	0.00157	0.0261	CcSEcCtD
Methylprednisolone—Optic neuritis—Cyclosporine—focal segmental glomerulosclerosis	0.00149	0.0247	CcSEcCtD
Methylprednisolone—Folliculitis—Cyclosporine—focal segmental glomerulosclerosis	0.00145	0.0241	CcSEcCtD
Methylprednisolone—Peptic ulcer—Cyclosporine—focal segmental glomerulosclerosis	0.00137	0.0227	CcSEcCtD
Methylprednisolone—Myopathy—Cyclosporine—focal segmental glomerulosclerosis	0.0013	0.0216	CcSEcCtD
Methylprednisolone—Fungal infection—Cyclosporine—focal segmental glomerulosclerosis	0.00118	0.0196	CcSEcCtD
Methylprednisolone—Abscess—Cyclosporine—focal segmental glomerulosclerosis	0.00116	0.0192	CcSEcCtD
Methylprednisolone—Tingling sensation—Cyclosporine—focal segmental glomerulosclerosis	0.00114	0.0189	CcSEcCtD
Methylprednisolone—Acne—Cyclosporine—focal segmental glomerulosclerosis	0.00109	0.018	CcSEcCtD
Methylprednisolone—Amenorrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00104	0.0173	CcSEcCtD
Methylprednisolone—Arthropathy—Cyclosporine—focal segmental glomerulosclerosis	0.00101	0.0167	CcSEcCtD
Methylprednisolone—Hiccups—Cyclosporine—focal segmental glomerulosclerosis	0.000914	0.0152	CcSEcCtD
Methylprednisolone—Fluid retention—Cyclosporine—focal segmental glomerulosclerosis	0.000868	0.0144	CcSEcCtD
Methylprednisolone—Neuropathy—Cyclosporine—focal segmental glomerulosclerosis	0.000858	0.0142	CcSEcCtD
Methylprednisolone—Oesophagitis—Cyclosporine—focal segmental glomerulosclerosis	0.000835	0.0139	CcSEcCtD
Methylprednisolone—Diabetes mellitus—Cyclosporine—focal segmental glomerulosclerosis	0.000763	0.0127	CcSEcCtD
Methylprednisolone—Injury—Cyclosporine—focal segmental glomerulosclerosis	0.000722	0.012	CcSEcCtD
Methylprednisolone—Increased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.000706	0.0117	CcSEcCtD
Methylprednisolone—Anaphylactoid reaction—Cyclosporine—focal segmental glomerulosclerosis	0.000686	0.0114	CcSEcCtD
Methylprednisolone—Cardiac failure—Cyclosporine—focal segmental glomerulosclerosis	0.00068	0.0113	CcSEcCtD
Methylprednisolone—Osteoarthritis—Cyclosporine—focal segmental glomerulosclerosis	0.000663	0.011	CcSEcCtD
Methylprednisolone—Affect lability—Cyclosporine—focal segmental glomerulosclerosis	0.000653	0.0108	CcSEcCtD
Methylprednisolone—Mood swings—Cyclosporine—focal segmental glomerulosclerosis	0.000629	0.0104	CcSEcCtD
Methylprednisolone—Breast disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0006	0.00995	CcSEcCtD
Methylprednisolone—Muscular weakness—Cyclosporine—focal segmental glomerulosclerosis	0.000585	0.00971	CcSEcCtD
Methylprednisolone—Abdominal distension—Cyclosporine—focal segmental glomerulosclerosis	0.000577	0.00958	CcSEcCtD
Methylprednisolone—Bronchospasm—Cyclosporine—focal segmental glomerulosclerosis	0.000564	0.00936	CcSEcCtD
Methylprednisolone—Pancreatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000562	0.00933	CcSEcCtD
Methylprednisolone—Sweating increased—Cyclosporine—focal segmental glomerulosclerosis	0.000559	0.00927	CcSEcCtD
Methylprednisolone—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.000522	0.00866	CcSEcCtD
Methylprednisolone—Infestation NOS—Cyclosporine—focal segmental glomerulosclerosis	0.000511	0.00848	CcSEcCtD
Methylprednisolone—Infestation—Cyclosporine—focal segmental glomerulosclerosis	0.000511	0.00848	CcSEcCtD
Methylprednisolone—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.000504	0.00836	CcSEcCtD
Methylprednisolone—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.000501	0.00832	CcSEcCtD
Methylprednisolone—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.000501	0.00832	CcSEcCtD
Methylprednisolone—Haemoglobin—Cyclosporine—focal segmental glomerulosclerosis	0.000461	0.00765	CcSEcCtD
Methylprednisolone—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.00046	0.00763	CcSEcCtD
Methylprednisolone—Haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.000459	0.00762	CcSEcCtD
Methylprednisolone—Connective tissue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000451	0.00748	CcSEcCtD
Methylprednisolone—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.000442	0.00734	CcSEcCtD
Methylprednisolone—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.000416	0.00691	CcSEcCtD
Methylprednisolone—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000414	0.00686	CcSEcCtD
Methylprednisolone—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.00041	0.0068	CcSEcCtD
Methylprednisolone—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000402	0.00667	CcSEcCtD
Methylprednisolone—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.0004	0.00663	CcSEcCtD
Methylprednisolone—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000371	0.00615	CcSEcCtD
Methylprednisolone—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.000365	0.00606	CcSEcCtD
Methylprednisolone—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.00036	0.00598	CcSEcCtD
Methylprednisolone—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.000359	0.00596	CcSEcCtD
Methylprednisolone—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.000346	0.00574	CcSEcCtD
Methylprednisolone—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.000345	0.00572	CcSEcCtD
Methylprednisolone—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.00034	0.00564	CcSEcCtD
Methylprednisolone—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.00034	0.00564	CcSEcCtD
Methylprednisolone—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.000339	0.00562	CcSEcCtD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.000338	0.0056	CcSEcCtD
Methylprednisolone—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000336	0.00558	CcSEcCtD
Methylprednisolone—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.000329	0.00546	CcSEcCtD
Methylprednisolone—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.000326	0.00541	CcSEcCtD
Methylprednisolone—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.000324	0.00537	CcSEcCtD
Methylprednisolone—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00032	0.00531	CcSEcCtD
Methylprednisolone—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000317	0.00526	CcSEcCtD
Methylprednisolone—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.000315	0.00523	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000297	0.00493	CcSEcCtD
Methylprednisolone—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.000295	0.00489	CcSEcCtD
Methylprednisolone—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000293	0.00486	CcSEcCtD
Methylprednisolone—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.000287	0.00476	CcSEcCtD
Methylprednisolone—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.000281	0.00466	CcSEcCtD
Methylprednisolone—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.000269	0.00446	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000267	0.00442	CcSEcCtD
Methylprednisolone—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.000259	0.0043	CcSEcCtD
Methylprednisolone—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000258	0.00428	CcSEcCtD
Methylprednisolone—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.00024	0.00399	CcSEcCtD
Methylprednisolone—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.000234	0.00388	CcSEcCtD
Methylprednisolone—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.000231	0.00383	CcSEcCtD
Methylprednisolone—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.000223	0.0037	CcSEcCtD
Methylprednisolone—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000216	0.00358	CcSEcCtD
Methylprednisolone—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.000207	0.00344	CcSEcCtD
Methylprednisolone—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000206	0.00341	CcSEcCtD
Methylprednisolone—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000205	0.00341	CcSEcCtD
Methylprednisolone—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000204	0.00339	CcSEcCtD
Methylprednisolone—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.000194	0.00321	CcSEcCtD
